Đang hiển thị 1 - 8 kết quả của 8 cho tìm kiếm '"Pharmacokinetics and pharmacodynamics"', thời gian truy vấn: 0.02s Tinh chỉnh kết quả
  1. 1
    Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

    Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cance... Bằng Aurelius Omlin (14971513)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

    Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer Bằng Aurelius Omlin (14971513)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Bằng Evan C. Chen (15054014)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Bằng Evan C. Chen (15054014)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Bằng Evan C. Chen (15054014)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Bằng Evan C. Chen (15054014)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Bằng Evan C. Chen (15054014)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Bằng Evan C. Chen (15054014)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: